Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
203.35 +5.87 / +2.97%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
202.50 -0.85 / -0.42%
 
Volume: 10.3K
QLT (QLTI) Reports Wider Year-over-Year Loss in Q4 - Analyst Blog
12:59pm / Zacks.com
Fastest-Growing Major Pharmaceutical
Feb 23 / TheStreet.com
3 Best Performing Stocks in February - Analyst Blog
11:16am / Zacks.com
Fastest-Growing Major Pharmaceutical
Feb 23 / TheStreet.com
5 Stocks With Jaw-Dropping Growth Potential
Feb 28 / MotleyFool.com
Valeant Surges on Salix Acquisition: What Wall Street's Saying
Feb 23 / TheStreet.com
Top 10 News for 2/23 - 2/27: Revised GDP Slips, but Beats, in Q4; Two Pharma Giants t...
Feb 27 / Investing Channel
Update: Marathon Pharma Sold Hospital Products To Valeant
Feb 23 / Benzinga
Whobs Next In The Pharma Buyout Boom?
Feb 26 / Investing Channel
Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher
Feb 23 / Benzinga
3 Stocks Boosting The Drugs Industry Higher
Feb 24 / TheStreet.com
Benzinga's Volume Movers
Feb 23 / Benzinga
Valeant Pharmaceuticals (VRX) Stock Higher Today as Analyst Increases Price Target on...
Feb 24 / TheStreet.com
Jim Cramer: Dollar General's Sales Accelerate, Valeant Is Undervalued
Feb 23 / TheStreet.com
Jim Cramer on Valeant: This Is an Amazing Pharmaceutical Firm
Feb 24 / TheStreet.com
Stocks Hitting 52-Week Highs
Feb 23 / Benzinga
Stock Market News for February 24, 2015 - Market News
Feb 24 / Zacks.com
Morning Market Gainers
Feb 23 / Benzinga
Valeant Pharmaceuticals (VRX) Earnings Report: Q4 2014 Conference Call Transcript
Feb 24 / TheStreet.com
Valeant Pharmaceuticals Earnings Eclipsed by the Salix Deal - Analyst Blog
Feb 23 / Zacks.com
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Feb 24 / Zacks.com
Notable Mergers and Acquisitions 2/23: (VRX)/(SLXP) (MMM)/(PPO) (AIR)/(TDG) (OCN)/(NS...
Feb 23 / Investing Channel
Jim Cramer Says Investors Should Buy Valeant Pharmaceuticals (VRX) After It Acquired ...
Feb 24 / TheStreet.com
Valeant Pharmaceuticals (VRX) Stock Surges Today as Analyst Ups Price Target on Salix...
Feb 23 / TheStreet.com
Jim Cramer's Top Stock Picks: AAPL DOW VRX XEC FTK
Feb 24 / TheStreet.com
Fed in Focus This Week - Ahead of Wall Street
Feb 23 / Zacks.com
Valeant Pharma (VRX) Soars on Salix Buy: 3 Keys for Investors - Stocks in the News
Feb 23 / Zacks.com
Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down
Feb 23 / Benzinga
Biotech Stocks Moving Higher
Feb 23 / Benzinga
Valeant Pharmaceuticals (VRX) Tops Estimates
Feb 23 / Investing Channel
Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instea...
Feb 23 / Benzinga
US Stock Futures Slip Ahead Of Economic Data
Feb 23 / Benzinga
Streetinsider.com's Hot Lunchtime Reads 2/23: (OCN) (GOOG) (SPPI) (ABT)
Feb 23 / Investing Channel
Frontrunning: February 23
Feb 23 / Investing Channel
Why Valeant Pharmaceuticals Int'l Inc.'s Shares Took Off Today
Feb 23 / MotleyFool.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account